Literature DB >> 30160072

Perceived benefits of and barriers to psychosocial risk screening in pediatric oncology by health care providers.

Maru Barrera1, Sarah Alexander2, Wendy Shama3, Denise Mills3, Leandra Desjardins1, Kelly Hancock1.   

Abstract

BACKGROUND: Although systematic psychosocial screening has been established as a standard of psychosocial care in pediatric oncology, this is not yet widely implemented in clinical practice. Limited information is available regarding the reasons behind this. In this study, we investigated perceptions of psychosocial screening by health care providers (HCPs) involved in pediatric cancer care.
METHODS: Using purposeful sampling, 26 HCPs (11 oncologists, 8 nurses, and 7 social workers) from a large North American pediatric cancer center participated in semistructured interviews. Interviews were recorded and transcribed verbatim. Themes were then derived using content analysis.
RESULTS: The themes were organized into perceived benefits of and barriers to psychosocial risk screening, and practical issues regarding implementation. Perceived benefits of screening included obtaining concise documentation of family psychosocial risk, identifying psychosocial factors important to medical treatment, starting a conversation, and triaging patients to psychosocial services. Barriers included perceived limited institutional support, commitment, and resources for psychosocial services, limited knowledge and appreciation of existing evidence-based validated tools, concerns about diverse family cultural backgrounds regarding psychosocial issues and language proficiency, and HCPs' personal values regarding psychosocial screening. Finally, practical issues of implementation including training in psychosocial risk screening, when and how to screen were discussed.
CONCLUSIONS: These findings highlight the importance of addressing HCPs' perceptions of benefits, barriers, and practical issues regarding implementing psychosocial risk screening.
© 2018 Wiley Periodicals, Inc.

Entities:  

Keywords:  oncology; pediatric; psychosocial; quality of life

Mesh:

Year:  2018        PMID: 30160072     DOI: 10.1002/pbc.27429

Source DB:  PubMed          Journal:  Pediatr Blood Cancer        ISSN: 1545-5009            Impact factor:   3.167


  4 in total

1.  Healthcare provider utility ratings of a psychosocial screening summary: from diagnosis to 6 months.

Authors:  Leandra Desjardins; Laurel Etkin-Spigelman; Kelly Hancock; Joanna Chung; Wendy Shama; Denise Mills; Sarah Alexander; Maru Barrera
Journal:  Support Care Cancer       Date:  2019-07-10       Impact factor: 3.603

2.  Using formative evaluation to plan for electronic psychosocial screening in pediatric oncology.

Authors:  Jordan Gilleland Marchak; Sean N Halpin; Cam Escoffery; Shadé Owolabi; Ann C Mertens; Karen Wasilewski-Masker
Journal:  Psychooncology       Date:  2020-10-20       Impact factor: 3.894

Review 3.  Advances in pediatric psychooncology.

Authors:  Lori Wiener; Katie A Devine; Amanda L Thompson
Journal:  Curr Opin Pediatr       Date:  2020-02       Impact factor: 2.856

4.  Protocol for mapping psychosocial screening to resources in pediatric oncology: a pilot randomized controlled trial.

Authors:  Leandra Desjardins; Kelly Hancock; Peter Szatmari; Sarah Alexander; Wendy Shama; Claire De Souza; Denise Mills; Oussama Abla; Maru Barrera
Journal:  Pilot Feasibility Stud       Date:  2021-07-17
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.